Page 147 - Read Online

Page 12 of 13 Ambe et al. Mini-invasive Surg 2018;2:37 I http://dx.doi.org/10.20517/2574-1225.2018.45

pectations and reality. Minim Invasive Ther Allied Technol 2016;25:241-6.
23. Kneist W, Wachter N, Paschold M, Kauff DW, Rink AD, et al. Midterm functional results of taTME with neuromapping for low rectal
cancer. Tech Coloproctol 2016;20:41-9.
24. Aretz S, Uhlhaas S, Sun Y, Pagenstecher C, Mangold E, et al. Familial adenomatous polyposis: aberrant splicing due to missense or si-
lent mutations in the APC gene. Hum Mutat 2004;24:370-80.
25. Bisgaard ML, Fenger K, Bülow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation
rate. Hum mutat 1994;3:121-5.
26. Knudsen AL, Bülow S, Tomlinson I, Möslein G, Heinimann K, et al. Attenuated familial adenomatous polyposis: results from an inter-
national collaborative study. Colorectal Dis 2010;12:e243-9.
27. Bülow S. Diagnosis of familial adenomatous polyposis. World J Surg 1991;15:41-6.
28. Dörner J, Fallahpour MT, Möslein G. Surgical management of hereditary colorectal cancer syndromes. In: Valle L, Gruber S, Capellá G,
editors. Hereditary colorectal cancer. Cham: Springer; 2018. pp. 327-47.
29. De Cosse JJ, Bülow S, Neale K, Järvinen H, Alm T, et al. Rectal cancer risk in patients treated for familial adenomatous polyposis. The
Leeds Castle polyposis group. Br J Surg 1992;79:1372-5.
30. Lynch HT, Smyrk T, McGinn T, Lanspa S, Cavalieri J, et al. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and
genotypically distinctive variant of FAP. Cancer 1995;76:2427-33.
31. Knudsen AL, Bisgaard ML, Bülow S. Attenuated familial adenomatous polyposis (AFAP): a review of the literature. Fam cancer
2003;2:43-55.
32. Groen EJ, Roos A, Muntinghe FL, Enting RH, de Vries J, et al. Extra-intestinal manifestations of familial adenomatous polyposis. Ann
Surg Oncol 2008;15:2439-50.
33. Traboulsi EI, Krush AJ, Gardner EJ, Booker SV, Offerhaus GJ, et al. Prevalence and importance of pigmented ocular fundus lesions in
Gardner’s syndrome. N Engl J Med 1987;316:661-7.
34. Naylor EW, Gardner EJ, Richards RC. Desmoid tumors and mesenteric fibromatosis in Gardner’s syndrome: report of kindred 109.
Arch Surg 1979;114:1181-5.
35. Vasen HF, Möslein G, Alonso A, Aretz S, Bernstein I, et al. Guidelines for the clinical management of familial adenomatous polyposis
(FAP). Gut 2008;57:704-13.
36. Lynch PM, Morris JS, Wen S, Advani SM, Ross W, et al. A proposed staging system and stage-specific interventions for familial adeno-
matous polyposis. Gastrointest Endosc 2016;84:115-25.
37. Ambe PC, Möslein G. Ileoanal pouch. Coloproctology 2018;40:130-5.
38. Remzi FH, Fazio VW, Delaney CP, Preen M, Ormsby A, et al. Dysplasia of the anal transitional zone after ileal pouch-anal anastomosis:
results of prospective evaluation after a minimum of ten years. Dis Colon Rectum 2003;46:6-13.
39. Carne PW, Pemberton JH. Technical aspects of ileoanal pouch surgery. Clin Colon Rectal Surg 2004;17:35-41.
40. Van Duijvendijk P, Slors JF, Taat CW, Oosterveld P, Sprangers MA, et al. Quality of life after total colectomy with ileorectal anastomo-
sis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 2000;87:590-6.
41. DE Marchis ML, Tonelli F, Quaresmini D, Lovero D, Della-Morte D, et al. Desmoid tumors in familial adenomatous polyposis. Anti-
cancer Res 2017;37:3357-66.
42. Ambe PC, Zirngibl H, Möslein G. Routine virtual ileostomy following restorative proctocolectomy for familial adenomatous polyposis.
World J Surg 2018;42:1867-71.
43. Monson JR, Arsalanizadeh R. Transanal total mesorectal excision (TaTME) and quality of rectal cancer surgery: do we really know?
Ann Surg 2017;266:e88-9.
44. Ambe PC, Zirngibl H, Möslein G. Initial experience with taTME in patients undergoing laparoscopic restorative proctocolectomy for
familial adenomatous polyposis. Tech Coloproctol 2017;21:971-4.
45. Reilly WT, Pemberton JH, Wolff BG, Nivatvongs S, Devine RM, et al. Randomized prospective trial comparing ileal pouch-anal anas-
tomosis performed by excising the anal mucosa to ileal pouch-anal anastomosis performed by preserving the anal mucosa. Ann Surg
1997;225:666-76.
46. Rullier E, Laurent C, Garrelon JL, Michel P, Saric J, et al. Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg
1998;85:355-8.
47. Aziz O, Albeyatti A, Derias M, Varsani N, Ashrafian H, et al. PTU-202 A case-controlled study demonstrating that changes associated
with rectal anastomotic leakage are detectable within 48 hours of surgery. Gut 2015;64:A152.
48. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, et al. Inherited variants of MYH associated with somatic G:C-->T:A
mutations in colorectal tumors. Nat Genet 2002;30:227-32.
49. Mazzei F, Viel A, Bignami M. Role of MUTYH in human cancer. Mutat Res 2013;743-744:33-43.
50. Nielsen M, Joerink-van de Beld MC, Jones N, Vogt S, Tops CM, et al. Analysis of MUTYH genotypes and colorectal phenotypes in pa-
tients With MUTYH-associated polyposis. Gastroenterology 2009;136:471-6.
51. Nieuwenhuis MH, Vogt S, Jones N, Nielsen M, Hes FJ, et al. Evidence for accelerated colorectal adenoma--carcinoma progression in
MUTYH-associated polyposis? Gut 2012;61:734-8.
52. De Rosa M, Galatola M, Quaglietta L, Miele E, De Palma G, et al. Alu-mediated genomic deletion of the serine/threonine protein kinase
11 (STK11) gene in Peutz-Jeghers syndrome. Gastroenterology 2010;138:2558-60.
53. Howe JR, Roth S, Ringold JC, Summers RW, Järvinen HJ, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science
1998;280:1086-8.
54. Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, et al. Germline mutations of the gene encoding bone morphogenetic protein
receptor 1A in juvenile polyposis. Nat Genet 2001;28:184-7.
55. Orloff MS, Eng C. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene 2008;27:5387-97.